A randomised, placebo-controlled clinical trial with the α2/3/5 subunit selective GABAA positive allosteric modulator PF-06372865 in patients with chronic low back pain - Gurrell, Rachel; Dua, Pinky; Feng, Gang; Sudworth, Maria; Whitlock, Mark; Reynolds, David S.; Butt, Richard P. (Pain (Amsterdam), 2018)
Keywords: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Chronic Pain - drug therapy; Double-Blind Method; Female; GABA Modulators - therapeutic use; Humans; Low Back Pain - drug therapy; Male; Middle Aged; Naproxen - therapeutic use; Pain Measurement; Receptors, GABA-A; Treatment Outcome; Young Adult